Abordagens terapêuticas e critérios para intervenção cirúrgica na adenomiose uterina: uma revisão integrativa

In: Journal of Medical and Biosciences Research · 2026 · vol. 3(6) · doi:10.70164/jmbr.v3i6.1409 · W7225312212
OA: hybrid CC0
⚙ AI-generated deep summary by qwen3.7-flash, 2026-11-09 · read from full text ⓘ

This integrative review analyzed 44 studies published between 2021 and 2026 to evaluate therapeutic approaches and surgical criteria for adenomyosis, focusing on efficacy, safety, and patient selection. The findings indicate that mifepristone significantly reduces pain compared to placebo, while dienogest often outperforms the levonorgestrel intrauterine system in pain relief, and focal ultrasound ablation achieved dysmenorrhea remission in 79% of cases. Recurrence rates varied by intervention, with adenomiomectomy showing 12.6%, embolization 29.5%, and thermal ablation 10.0%, though the QUESTA trial failed to demonstrate non-inferiority of embolization versus hysterectomy. The authors note a lack of validated explicit selection criteria and a predominance of short-term data from Asian centers, with no primary Brazilian studies included. This paper is centrally about adenomyosis — specifically evaluating conservative treatments, uterine-sparing surgeries, and hysterectomy outcomes for symptomatic disease.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

A adenomiose causa dismenorreia, sangramento uterino aumentado e infertilidade, e a escolha entre tratamento medicamentoso, procedimentos que preservam o útero e cirurgia carece de critérios consolidados. Esta revisão integrativa analisou as evidências publicadas entre 2021 e 2026 sobre eficácia, segurança e seleção de pacientes nas abordagens terapêuticas da adenomiose, com ênfase nos critérios para intervenção cirúrgica. A busca foi feita em 4 de novembro de 2026 no PubMed/MEDLINE, na LILACS e na SciELO, com relato orientado pelo PRISMA 2020 e nível de evidência segundo Melnyk e Fineout-Overholt. Dos 198 registros identificados, 44 estudos foram incluídos: 24 revisões sistemáticas, 10 ensaios clínicos randomizados e 10 estudos observacionais. A mifepristona reduziu a dor em 6,63 pontos na escala visual analógica, contra 0,95 com placebo, e o dienogeste superou o sistema intrauterino de levonorgestrel no alívio da dor em parte dos estudos. A ablação por ultrassom focalizado obteve remissão da dismenorreia em 79% dos casos, com recorrência de 20%. Em metanálise de estudos de braço único, a recorrência foi de 12,6% após adenomiomectomia, 29,5% após embolização e 10,0% após ablação térmica, e o estudo QUESTA não demonstrou não inferioridade da embolização frente à histerectomia. Critérios explícitos de escolha (idade, paridade, subtipo, espessura miometrial ou tamanho do útero) foram descritos em um único estudo, sem validação. Nenhum estudo primário brasileiro foi incluído. Os dados são compatíveis com escolha individualizada, mas vêm sobretudo de estudos de curto prazo e de centros asiáticos.
Full text 13,397 characters · extracted from oa-doi-fallback · click to expand
Abordagens terapêuticas e critérios para intervenção cirúrgica na adenomiose uterina: uma revisão integrativa DOI: https://doi.org/10.70164/jmbr.v3i6.1409Keywords: Adenomiose; Tratamento Conservador; Progestinas; Embolização da Artéria Uterina; Histerectomia; Preservação da Fertilidade.Abstract A adenomiose causa dismenorreia, sangramento uterino aumentado e infertilidade, e a escolha entre tratamento medicamentoso, procedimentos que preservam o útero e cirurgia carece de critérios consolidados. Esta revisão integrativa analisou as evidências publicadas entre 2021 e 2026 sobre eficácia, segurança e seleção de pacientes nas abordagens terapêuticas da adenomiose, com ênfase nos critérios para intervenção cirúrgica. A busca foi feita em 4 de novembro de 2026 no PubMed/MEDLINE, na LILACS e na SciELO, com relato orientado pelo PRISMA 2020 e nível de evidência segundo Melnyk e Fineout-Overholt. Dos 198 registros identificados, 44 estudos foram incluídos: 24 revisões sistemáticas, 10 ensaios clínicos randomizados e 10 estudos observacionais. A mifepristona reduziu a dor em 6,63 pontos na escala visual analógica, contra 0,95 com placebo, e o dienogeste superou o sistema intrauterino de levonorgestrel no alívio da dor em parte dos estudos. A ablação por ultrassom focalizado obteve remissão da dismenorreia em 79% dos casos, com recorrência de 20%. Em metanálise de estudos de braço único, a recorrência foi de 12,6% após adenomiomectomia, 29,5% após embolização e 10,0% após ablação térmica, e o estudo QUESTA não demonstrou não inferioridade da embolização frente à histerectomia. Critérios explícitos de escolha (idade, paridade, subtipo, espessura miometrial ou tamanho do útero) foram descritos em um único estudo, sem validação. Nenhum estudo primário brasileiro foi incluído. Os dados são compatíveis com escolha individualizada, mas vêm sobretudo de estudos de curto prazo e de centros asiáticos. References AHN, J. W. et al. Minimally invasive adenomyomectomy via a laparoscopic-assisted approach compared to a laparoscopic or laparotomic approach. Taiwanese Journal of Obstetrics & Gynecology, v. 60, n. 6, p. 1005-1010, 2021. AKHIGBE, R. E. et al. Comparison of the effectiveness of levonorgestrel intrauterine system and dienogest in the management of adenomyosis: A systematic review and meta-analysis. European Journal of Obstetrics, Gynecology, and Reproductive Biology, v. 300, p. 230-239, 2024 ALI, M. K. et al. The use of dienogest in treatment of symptomatic adenomyosis: A systematic review and meta-analysis. Journal of Gynecology Obstetrics and Human Reproduction, v. 53, n. 7, art. 102795, 2024. CATHERINO, W. H. et al. Efficacy and safety of relugolix combination therapy in women with uterine fibroids and adenomyosis: subgroup analysis of LIBERTY 1 and LIBERTY 2. Fertility and Sterility, v. 124, n. 3, p. 523-533, 2025. CHE, X. et al. Effect of Mifepristone vs Placebo for Treatment of Adenomyosis With Pain Symptoms: A Randomized Clinical Trial. JAMA Network Open, v. 6, n. 6, art. e2317860, 2023. CHEN, Y. et al. Systematic review and meta-analysis of reproductive outcomes after high-intensity focused ultrasound (HIFU) treatment of adenomyosis. Best Practice & Research. Clinical Obstetrics & Gynaecology, v. 92, art. 102433, 2024. CHENE, G. et al. The role of progestin subdermal implant in the management of adenomyosis: a systematic review. The European Journal of Contraception & Reproductive Health Care, v. 29, n. 2, p. 61-68, 2024. COMISSÃO NACIONAL DE INCORPORAÇÃO DE TECNOLOGIAS NO SUS (CONITEC). Protocolo Clínico e Diretrizes Terapêuticas Endometriose: Relatório de Recomendação n. 1050. Brasília, DF: Ministério da Saúde, set. 2025. Aprovado pela Portaria Conjunta SAES/SAPS/SCTIE n. 54, de 2 de junho de 2026. DAI, Y. et al. Treatment strategies for adenomyosis before and after introducing USgHIFU in Shenzhen. International Journal of Hyperthermia, v. 42, n. 1, art. 2501244, 2025. DASON, E. S. et al. Guideline No. 437: Diagnosis and Management of Adenomyosis. Journal of Obstetrics and Gynaecology Canada, v. 45, n. 6, p. 417-429.e1, 2023. ETRUSCO, A. et al. Efficacy and safety of hormone therapies for treating adenomyosis-associated pelvic pain: a systematic review and network meta-analysis of randomized controlled trials. Frontiers in Endocrinology, v. 16, art. 1571727, 2025. GUO, W. et al. Compare the Efficacy of Dienogest and the Levonorgestrel Intrauterine System in Women with Adenomyosis. Clinical Therapeutics, v. 45, n. 10, p. 973-976, 2023. HAKIMI, P. et al. The impact of vaginal bromocriptine on reducing pain and menstrual bleeding in women with adenomyosis: a randomized controlled trial. Scientific Reports, v. 16, n. 1, art. 24086, 2026. HASSANIN, A. I. et al. Comparison of dienogest versus combined oral contraceptive pills in the treatment of women with adenomyosis: A randomized clinical trial. International Journal of Gynaecology and Obstetrics, v. 154, n. 2, p. 263-269, 2021. HU, L. et al. Long-term efficacy and reintervention of focused ultrasound ablation surgery monotherapy for adenomyosis: a systematic review and meta-analysis. Frontiers in Medicine, v. 13, art. 1855726, 2026. JIANG, L. et al. Pregnancy Outcomes after Uterus-sparing Operative Treatment for Adenomyosis: A Systematic Review and Meta-analysis. Journal of Minimally Invasive Gynecology, v. 30, n. 7, p. 543-554, 2023. JONSDOTTIR, G. et al. Symptom improvement in adenomyosis patients after ultrasound guided microwave ablation or uterine artery embolization, A randomized controlled pilot study. PLOS ONE, v. 21, n. 3, art. e0343949, 2026. KALE, A. et al. Focal and Diffuse Adenomyomectomy: A Systematic Review of Comparative Outcomes From Published Studies Including 3397 Patients. Journal of Minimally Invasive Gynecology, v. 33, n. 10, p. 1409-1421, 2026. KOBAYASHI, H.; IMANAKA, S. Proposal for developing treatment algorithms of women with symptomatic adenomyosis: A single-center experience. The Journal of Obstetrics and Gynaecology Research, v. 47, n. 9, p. 3257-3268, 2021. LEE, Y. L. et al. Effectiveness of high-intensity focused ultrasound combined with gonadotropin-releasing hormone agonist or combined with levonorgestrel-releasing intrauterine system for adenomyosis: A systematic review and meta-analysis. Taiwanese Journal of Obstetrics & Gynecology, v. 63, n. 4, p. 492-499, 2024. LI, P. et al. Clinical efficacy and safety of indomethacin-gyneFix IUD combined with a levonorgestrel-releasing intrauterine system in patients with adenomyosis and different uterine cavity depths. Pakistan Journal of Pharmaceutical Sciences, v. 39, n. 10, p. 2979-2990, 2026. LI, S. et al. Comparison of safety and efficacy of hysteroscopic LNG-IUS fixation surgery and conventional LNG-IUS placement in the treatment of adenomyosis: A retrospective cohort study. Medicine, v. 104, n. 44, art. e44941, 2025. LIANG, J. et al. Pregnancy Outcomes of Adenomyosis after Treatment with High-intensity Focused Ultrasound: a Systematic Review and Meta Analysis. Reproductive Sciences (Thousand Oaks, Calif.), v. 33, n. 1, p. 75-83, 2026. LIANG, Y.; XIAO, T.; ZHANG, H. Comparative analysis of the clinical efficacy of conservative treatment for adenomyosis using traditional Chinese medicine and Western medicine. Journal of Health, Population, and Nutrition, v. 44, n. 1, art. 116, 2025. LIN, S. et al. Dienogest treatment of symptomatic adenomyosis: An in-depth meta-analysis. European Journal of Obstetrics, Gynecology, and Reproductive Biology, v. 305, p. 365-374, 2025. LIN, T. et al. A clinical study on the efficacy of a novel herbal medicine cocktail in enhancing HIFU treatment for adenomyosis: a pilot randomized controlled trial. International Journal of Hyperthermia, v. 43, n. 1, art. 2729542, 2026. LIU, L.; WANG, T.; LEI, B. Image-guided thermal ablation in the management of symptomatic adenomyosis: a systematic review and meta-analysis. International Journal of Hyperthermia, v. 38, n. 1, p. 948-962, 2021. LIU, L. et al. Risk of Recurrence and Reintervention After Uterine-Sparing Interventions for Symptomatic Adenomyosis: A Systematic Review and Meta-Analysis. Obstetrics and Gynecology, v. 141, n. 4, p. 711-723, 2023. LIU, L. et al. Comparative analysis of the efficacy of dienogest and LNG-IUS in the treatment of intrinsic and extrinsic subtypes of adenomyosis. Zhonghua Fu Chan Ke Za Zhi, v. 60, n. 4, p. 281-288, 2025a. LIU, L. et al. Reproductive outcomes after fertility-sparing interventions for symptomatic adenomyosis: a systematic review and meta-analysis. BMC Pregnancy and Childbirth, v. 25, n. 1, art. 1178, 2025b. MELNYK, B. M.; FINEOUT-OVERHOLT, E. Evidence-based practice in nursing & healthcare: a guide to best practice. 4. ed. Philadelphia: Wolters Kluwer, 2019. MENDES, K. D. S.; SILVEIRA, R. C. C. P.; GALVÃO, C. M. Revisão integrativa: método de pesquisa para a incorporação de evidências na saúde e na enfermagem. Texto & Contexto - Enfermagem, v. 17, n. 4, p. 758-764, 2008. OTGONTUYA, A. et al. Comparison of the treatment efficacies of HIFU, HIFU combined with GnRH-a, and HIFU combined with GnRH-a and LNG-IUS for adenomyosis: A systematic review and meta-analysis. Taiwanese Journal of Obstetrics & Gynecology, v. 62, n. 2, p. 226-238, 2023. OTGONTUYA, A. et al. Improving the symptoms of dysmenorrhea and menorrhagia of women with adenomyosis and myoma in short- and long-term treatment effectiveness of microwave ablation: A systematic review and meta-analysis. Taiwanese Journal of Obstetrics & Gynecology, v. 65, n. 2, p. 188-197, 2026. PAGE, M. J. et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ, v. 372, art. n71, 2021. PANG, L. L. et al. Efficacy of High-Intensity Focused Ultrasound Combined With GnRH-a for Adenomyosis: A Systematic Review and Meta-Analysis. Frontiers in Public Health, v. 9, art. 688264, 2021. PEKER, M. E. et al. Comparison of the effects of levonorgestrel-releasing intrauterine system and dienogest treatment on systemic inflammatory markers (NLR, PLR, SII) and anemia parameters in patients with adenomyosis at 6 months. International Journal of Gynaecology and Obstetrics, v. 174, n. 2, p. 817-823, 2026. RATHINAM, K. K. et al. Evaluation of pharmacological interventions in the management of adenomyosis: a systematic review. European Journal of Clinical Pharmacology, v. 78, n. 4, p. 531-545, 2022. REFAAT, R. et al. Uterine artery embolization versus dienogest for symptomatic adenomyosis: A randomized controlled trial of short-term efficacy. European Journal of Radiology, v. 196, art. 112712, 2026. SHARMA, S. et al. Low-dose letrozole - an effective option for women with symptomatic adenomyosis awaiting IVF: a pilot randomized controlled trial. Reproductive Biomedicine Online, v. 47, n. 1, p. 84-93, 2023. SONG, Y.; WANG, L. Combining Medication With High-Intensity-Focused Ultrasound for Adenomyosis: A Network Meta-Analysis of Randomized Controlled Trials. Journal of Ultrasound in Medicine, v. 44, n. 3, p. 445-466, 2025. SU, S. et al. Comparison Between Levonorgestrel-Releasing Intrauterine Device and Dienogest for Adenomyosis: A Systematic Review with Meta-Analysis. Journal of Obstetrics and Gynaecology Canada, v. 48, n. 2, art. 103147, 2026. SUN, F. et al. Thermal Ablation and Thermal Ablation Combined With Medical Therapy for Adenomyosis: A Systematic Review and Network Meta-Analysis. Ultrasound in Medicine & Biology, v. 52, n. 6, p. 993-1001, 2026. TROMMELEN, L. M. et al. Quality of life 1 year after uterine artery embolization vs hysterectomy for symptomatic adenomyosis (QUESTA study). Acta Obstetricia et Gynecologica Scandinavica, v. 104, n. 8, p. 1558-1574, 2025. WANG, M. H. et al. Global prevalence of adenomyosis and endometriosis: a systematic review and meta-analysis. Reproductive Biology and Endocrinology, v. 23, n. 1, art. 148, 2025. WANG, Y.; WANG, X.; ZHANG, L. Therapeutic efficacy of dienogest combined with GnRH agonist in adenomyosis and associated obstetric risk factors: A meta-analysis. Medicine, v. 104, n. 48, art. e45907, 2025. WHITTEMORE, R.; KNAFL, K. The integrative review: updated methodology. Journal of Advanced Nursing, v. 52, n. 5, p. 546-553, 2005. XIE, L. et al. The present adenomyosis treatment status in Luzhou, China: a small scope observational cross-sectional survey. BMC Women's Health, v. 25, n. 1, art. 92, 2025. ZHANG, B. et al. The role of different LNG-IUS therapies in the management of adenomyosis: a systematic review and meta-analysis. Reproductive Biology and Endocrinology, v. 23, n. 1, art. 23, 2025. ZHAO, T. T. et al. Efficacy of high-intensity focused ultrasound combined with LNG-IUS for adenomyosis: a systematic review and meta-analysis. Archives of Gynecology and Obstetrics, v. 308, n. 2, p. 351-362, 2023. ZHAO, X. et al. Comparative study of female sexual function in adenomyosis patients who received the treatment of intensity-focused ultrasound ablation or laparoscopic total hysterectomy. International Journal of Gynaecology and Obstetrics, v. 174, n. 1, p. 166-173, 2026. Published How to Cite Issue Section License Copyright (c) 2026 João Gabriel Garrote Vasconcelos, Daiana Caide Lopes Brandenburg, Marcela Carvalho Marcovechio Fonseca, Emerson Oliveira Lise, Maria Clara Pereira Prado Nunes, Sophia Leite Arantes, Brunno Rolo This work is licensed under a Creative Commons Attribution 4.0 International License.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (40)

Source provenance

openalex
last seen: 2026-11-17T06:02:21.439193+00:00
License: CC0 · commercial use OK